FDA Drug Application (020839) for PLAVIX by SANOFI AVENTIS US

Back to FDA Applications sponsored by SANOFI AVENTIS US

Application Number020839
Product Number001
FormTABLET;ORAL
DosageEQ 75MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NamePLAVIX
Active IngredientCLOPIDOGREL BISULFATE

Active IngredientCount
List of drugs with Active Ingredient CLOPIDOGREL BISULFATE2


Back to FDA Applications sponsored by SANOFI AVENTIS US